J.B. Chemicals & Pharmaceuticals Ltd., has today announced the appointment of Nikhil Chopra as whole-time Director and Chief Executive Officer of the company for a period of five years from the appointment date. This appointment is subject to approval by the members of the company at next general meeting. 

 

Prior to joining the company, Nikhil Chopra worked as Head-India Business at Cipla Limited.

 

Nikhil is a business leader with over 20 years of experience backed up with consistent record of sustainable growth and shareholder value creation. For over two decades, he has spearheaded breakthrough ideas focused on creating greater access to high quality treatment & medicines, and gain a significant competitive advantage over peers, especially in therapies such as Respiratory, Urology HIV and Paediatric Care.

 

He has led and managed diversified boards, teams and cross functions to drive business outcomes as aligned with strategic growth plans. He played a key role in forging strategic partnerships with innovator companies for patented medicines and new drug delivery systems, thereby expanding footprint in therapies such as Cardiology, Diabetes and Oncology

 

Nikhil had also spearheaded implementation for the largest patient support program in the field of respiratory which ensures more than 2 million patient touchpoints every year

 

He holds M.Sc. (Organic Chemistry) from Gujarat University.